CD40 Expression in Fibrocytes Is Induced by TSH: Potential Synergistic Immune Activation.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27631497)

Published in PLoS One on September 15, 2016

Authors

Tünde Mester1, Nupur Raychaudhuri1, Erin F Gillespie1, Hong Chen1,2, Terry J Smith1,3, Raymond S Douglas1,4

Author Affiliations

1: Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, 48105, United States of America.
2: Department of Ophthalmology of Union Hospital, Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, People's Republic of China.
3: Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, 48105, United States of America.
4: Ann Arbor Veterans Administration Medical Center, Ann Arbor, Michigan, 48105, United States of America.

Articles cited by this

Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med (1994) 7.19

Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 4.41

Thyroid-stimulating immunoglobulins in Graves' disease. Lancet (1974) 2.84

Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol (2003) 2.67

Increased generation of fibrocytes in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab (2009) 2.10

CD40 and autoimmunity: the dark side of a great activator. Semin Immunol (2009) 1.80

Fibrocyte activation in rheumatoid arthritis. Rheumatology (Oxford) (2009) 1.68

Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid (2010) 1.67

A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. Genes Immun (2007) 1.66

Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. J Immunol (2008) 1.45

Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression. Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy. J Biol Chem (1998) 1.34

Peripheral blood fibrocytes: mesenchymal precursor cells and the pathogenesis of fibrosis. Curr Rheumatol Rep (2000) 1.25

Persistent cAMP signaling by internalized TSH receptors occurs in thyroid but not in HEK293 cells. FASEB J (2012) 1.17

Expression of CD154 (CD40 ligand) by human lung fibroblasts: differential regulation by IFN-gamma and IL-13, and implications for fibrosis. J Immunol (2004) 1.14

Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. Invest Ophthalmol Vis Sci (2008) 1.10

Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy. Thyroid (2002) 1.08

Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production. J Clin Endocrinol Metab (2012) 1.08

Immune mechanisms in thyroid eye disease. Thyroid (2008) 1.05

Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease. J Clin Endocrinol Metab (2011) 1.05

Dominant infiltration of T(H)1-type CD4+ T cells at the retrobulbar space of patients with thyroid-associated ophthalmopathy. Thyroid (1999) 0.99

Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB. Invest Ophthalmol Vis Sci (2012) 0.94

PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated ophthalmopathy. PLoS One (2010) 0.93

Thyrotropin regulates IL-6 expression in CD34+ fibrocytes: clear delineation of its cAMP-independent actions. PLoS One (2013) 0.92

Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes. J Clin Endocrinol Metab (2014) 0.90

Costimulation blockade in the treatment of rheumatic diseases. BioDrugs (2004) 0.85

G13-dependent activation of MAPK by thyrotropin. J Biol Chem (2008) 0.83

Is IGF-I receptor a target for autoantibody generation in Graves' disease? J Clin Endocrinol Metab (2013) 0.82

Regulation of IL-1 receptor antagonist by TSH in fibrocytes and orbital fibroblasts. J Clin Endocrinol Metab (2014) 0.80

TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist. PLoS One (2015) 0.80

Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy. Exp Eye Res (2016) 0.80

Relative levels of the inflammatory cytokine TNFα and the soluble CD40 ligand profile in serum correlate with the thyrotoxic activity of Graves' disease. Thyroid (2012) 0.79

Migrating lymph dendritic cells contain intracellular CD40 that is mobilized to the immunological synapse during interactions with antigen-specific T lymphocytes. J Immunol (2012) 0.78

Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2014) 0.77

The role of osteopontin in the induction of the CD40 ligand in Graves' disease. Clin Endocrinol (Oxf) (2013) 0.77